Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.
This study has been completed.
Study NCT00356447   Information provided by Bayer
First Received: July 25, 2006   Last Updated: October 27, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Vasomotor Symptoms
Interventions listed in this trial
Angeliq
Placebo
Additional drug interventions recognized in this trial
Drospirenone
Estradiol
More general drug interventions related to this trial
Aldosterone Antagonists
Estrogens
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services